Follow
Ayrea Hurley
Ayrea Hurley
Arrowhead Pharmaceuticals
Verified email at arrowheadpharma.com
Title
Cited by
Cited by
Year
AAV-CRISPR gene editing is negated by pre-existing immunity to Cas9
A Li, MR Tanner, CM Lee, AE Hurley, M De Giorgi, KE Jarrett, TH Davis, ...
Molecular Therapy 28 (6), 1432-1441, 2020
1712020
A self-deleting AAV-CRISPR system for in vivo genome editing
A Li, CM Lee, AE Hurley, KE Jarrett, M De Giorgi, W Lu, KS Balderrama, ...
Molecular Therapy-Methods & Clinical Development 12, 111-122, 2018
1262018
Somatic Editing of Ldlr With Adeno-Associated Viral-CRISPR Is an Efficient Tool for Atherosclerosis Research
KE Jarrett, C Lee, M De Giorgi, A Hurley, BK Gillard, AM Doerfler, A Li, ...
Arteriosclerosis, thrombosis, and vascular biology 38 (9), 1997-2006, 2018
752018
TFEB regulates murine liver cell fate during development and regeneration
N Pastore, T Huynh, NJ Herz, A Calcagni’, TJ Klisch, L Brunetti, KH Kim, ...
Nature communications 11 (1), 2461, 2020
402020
Depletion of essential isoprenoids and ER stress induction following acute liver-specific deletion of HMG-CoA reductase
M De Giorgi, KE Jarrett, JC Burton, AM Doerfler, A Hurley, A Li, RH Hsu, ...
Journal of lipid research 61 (12), 1675-1686, 2020
192020
Use of synthetic urine as a matrix substitute for standard and quality control materials in the clinical assessment of iodine by inductively coupled plasma mass spectrometry
CJ Haglock-Adler, A Hurley, FG Strathmann
Clinical Biochemistry 47 (15), 80-82, 2014
192014
In vivo genome editing at the albumin locus to treat methylmalonic acidemia
JL Schneller, CM Lee, LE Venturoni, RJ Chandler, A Li, S Myung, ...
Molecular Therapy-Methods & Clinical Development 23, 619-632, 2021
122021
Targeting the Apoa1 locus for liver-directed gene therapy
M De Giorgi, A Li, A Hurley, M Barzi, AM Doerfler, NA Cherayil, HE Smith, ...
Molecular Therapy Methods & Clinical Development 21, 656-669, 2021
122021
LPA disruption with AAV-CRISPR potently lowers plasma apo (a) in transgenic mouse model: A proof-of-concept study
AM Doerfler, SH Park, JM Assini, A Youssef, L Saxena, AB Yaseen, ...
Molecular Therapy-Methods & Clinical Development 27, 337-351, 2022
112022
Highly conserved amino acid residues in apolipoprotein A1 discordantly induce high density lipoprotein assembly in vitro and in vivo
D Yelamanchili, J Liu, AM Gotto Jr, AE Hurley, WR Lagor, BK Gillard, ...
Biochimica et Biophysica Acta (BBA)-Molecular and Cell Biology of Lipids …, 2020
32020
Speg interactions that regulate the stability of excitation-contraction coupling protein complexes in triads and dyads
CS Lee, SY Jung, RSZ Yee, NH Agha, J Hong, T Chang, LW Babcock, ...
Communications Biology 6 (1), 942, 2023
22023
In vivo expansion of gene-targeted hepatocytes through transient inhibition of an essential gene
M De Giorgi, SH Park, A Castoreno, M Cao, A Hurley, L Saxena, ...
bioRxiv, 2023
22023
Intestinal deletion of 3-Hydroxy-3-Methylglutaryl-Coenzyme A Reductase promotes expansion of the resident stem cell compartment
AM Doerfler, J Han, KE Jarrett, L Tang, A Jain, A Saltzman, M De Giorgi, ...
Arteriosclerosis, thrombosis, and vascular biology 42 (4), 381-394, 2022
12022
In vivo Genome Editing to Treat Methylmalonic Acidemia (MMA) Caused by Methylmalonyl-CoA Mutase Deficiency (hMUT)
JL Schneller, CM Lee, A Li, TJ Cradick, RJ Chandler, AE Hurley, ...
MOLECULAR THERAPY 27 (4), 369-369, 2019
12019
Encapsulation of AAVs into protein vault nanoparticles as a novel solution to gene therapy’s neutralizing antibody problem
LT Collins, W Beatty, B Moyo, M Alves-Bezerra, A Hurley, Q Lou, ZH Zhou, ...
bioRxiv, 2023.11. 29.569229, 2023
2023
Adeno-Associated virus 8 delivers an immunomodulatory peptide to mouse liver more efficiently than to rat liver
Y Wang, A Hurley, M De Giorgi, MR Tanner, RC Hu, MW Pennington, ...
Plos one 18 (4), e0283996, 2023
2023
Deletion of 3-Hydroxy-3-Methylglutaryl-Coenzyme A Reductase Promotes Expansion of the Resident Stem Cell Compartment
A Doerfler, J Han, K Jarrett, L Tang, A Jain, A Saltzman, M De Giorgi, ...
Health Research Alliance, 2023
2023
Selective expansion of gene-targeted cells
W Lagor, A Hurley, K Jarrett, KD Bissing, M De Giorgi, M Furgurson
US Patent App. 17/756,242, 2023
2023
Genetic Inhibition Of Hepatic Dolichol Biosynthesis Results In Hypolipidemia
M De Giorgi, AM Doerfler, A Hurley, C Walkey, WR Lagor
Arteriosclerosis, Thrombosis, and Vascular Biology 42 (Suppl_1), A425-A425, 2022
2022
In Vivo Expansion of Gene-Targeted Hepatocytes Through Inhibition of an Essential Gene
M De Giorgi, A Hurley, AM Doerfler, MN Furgurson, MA Chuecos, S Hyde, ...
MOLECULAR THERAPY 30 (4), 568-569, 2022
2022
The system can't perform the operation now. Try again later.
Articles 1–20